폐 및 호흡기 약물전달 시장 보고서(2026년)

Pulmonary or respiratory drug delivery involves administering medication directly into the lungs to ensure rapid absorption, focused treatment, and minimized systemic side effects, providing both local and systemic therapeutic benefits.

The primary categories of pulmonary or respiratory drug delivery are based on formulation type and device type. Formulation type refers to the method of preparing drugs to ensure effective administration, accurate dosing, and proper absorption in the body. The different canister types include plain canisters and coated canisters. These are utilized for various applications such as chronic obstructive pulmonary disease, asthma, cystic fibrosis, and other conditions. They are also employed by different end-users, including hospitals, clinics, and home care settings.

Tariffs have affected the pulmonary drug delivery market by increasing the cost of imported devices, propellant canisters, and formulation components used in inhalation therapies. The impact is most visible in inhaler and nebulizer segments, where device precision and component availability are critical. Regions such as Asia Pacific and Europe have experienced higher input costs due to reliance on cross border medical device supply chains. Rising tariff related expenses have influenced product pricing, procurement decisions, and launch timelines. However, tariffs have supported local device manufacturing, encouraged innovation in inhalation technologies, and strengthened regional production ecosystems over the long term.

The pulmonary or respiratory drug delivery market research report is one of a series of new reports from The Business Research Company that provides pulmonary or respiratory drug delivery market statistics, including pulmonary or respiratory drug delivery industry global market size, regional shares, competitors with a pulmonary or respiratory drug delivery market share, detailed pulmonary or respiratory drug delivery market segments, market trends and opportunities, and any further data you may need to thrive in the pulmonary or respiratory drug delivery industry. This pulmonary or respiratory drug delivery market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pulmonary or respiratory drug delivery market size has grown strongly in recent years. It will grow from $75.67 billion in 2025 to $82.23 billion in 2026 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to rising asthma and copd prevalence, widespread inhaler adoption, growth in respiratory hospitals, improved aerosol technologies, expansion of homecare treatments.

The pulmonary or respiratory drug delivery market size is expected to see strong growth in the next few years. It will grow to $114.23 billion in 2030 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to aging population, rising air pollution exposure, growth in digital inhalers, expansion of homecare settings, increasing chronic respiratory conditions. Major trends in the forecast period include rising adoption of inhalation-based drug delivery, increasing demand for home-based respiratory therapies, growing use of dry powder and metered dose inhalers, expansion of chronic respiratory disease management, increased focus on patient-friendly delivery devices.

The rising prevalence of pneumonia is expected to drive the growth of the pulmonary or respiratory drug delivery market in the coming years. Pneumonia is a lung infection that causes inflammation of the air sacs, which may fill with fluid or pus, resulting in symptoms such as cough, fever, and difficulty breathing. Factors contributing to the increasing prevalence of pneumonia include aging populations, weakened immune systems, respiratory infections, air pollution, smoking, and the emergence of antibiotic-resistant bacteria. Pulmonary or respiratory drug delivery assists pneumonia patients by directly targeting the lungs with medications, including antibiotics, bronchodilators, or anti-inflammatory agents, allowing for faster and more effective treatment to relieve symptoms, reduce inflammation, eliminate infections, and improve respiratory function, ultimately supporting recovery and preventing complications. For example, in December 2024, Clinical Trials Arena, a UK-based clinical research news platform, reported that hospital admissions for Mycoplasma pneumoniae rose by 461% from October 2023 to February 2024, increasing from 110 to 617 admissions, with 20.2% of pneumonia cases detected in children aged 0 to 4 years, 25.4% in children aged 5 to 9 years, and 17.5% in children aged 10 to 14 years, accounting for 410 of the 650 cases reported. Consequently, the growing prevalence of pneumonia fuels the pulmonary or respiratory drug delivery market.

Major companies operating in the pulmonary or respiratory drug delivery market are concentrating on technological innovations such as sophisticated drug delivery systems that improve treatment effectiveness and patient adherence. Sophisticated drug delivery systems are advanced technologies that facilitate targeted delivery and controlled release of therapeutic agents, enhancing drug performance and patient outcomes. For example, in July 2023, Viatris Inc., a US-based healthcare company that produces generic and branded medications, and Kindeva Drug Delivery L.P., a US-based firm specializing in drug delivery, launched Breyna (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol, an inhalation aerosol approved by the Food and Drug Administration, a US government agency. This is the first generic version of AstraZeneca's Symbicort and a metered-dose inhaler combining budesonide and formoterol for the treatment of asthma and chronic obstructive pulmonary disease. It is offered in two strengths of 80 micrograms and 160 micrograms with 4.5 micrograms of formoterol.

In January 2025, Molex LLC, a US-based electronic solutions provider and parent company of Phillips-Medisize, acquired Vectura Group Ltd. for an undisclosed amount. Through this acquisition, Molex intends to strengthen Phillips-Medisize's pulmonary and respiratory drug delivery capabilities by incorporating Vectura's advanced inhalation device technologies, supporting the development of next-generation inhalation therapies and broadening its global product portfolio. Vectura Group Ltd. is a UK-based provider of inhalation drug delivery systems with a strong history of innovation in respiratory therapy devices.

Major companies operating in the pulmonary or respiratory drug delivery market are Merck & Co. Inc., Novartis AG, Thermo Fisher Scientific Inc., AstraZeneca plc, Abbott Laboratories, 3M Company, Koninklijke Philips N.V., GlaxoSmithKline, Omron Corporation, Teva Pharmaceutical Industries Ltd., Aptar Pharma, Sumitomo Pharma America Inc., Chiesi Farmaceutici S.p.A., Cipla Inc., Boehringer Ingelheim GmbH, Kindeva Drug Delivery Limited, Nemera Group, Hovione, H And T Presspart Group, Vectura Group plc

North America was the largest region in the pulmonary or respiratory drug delivery market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pulmonary or respiratory drug delivery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pulmonary or respiratory drug delivery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pulmonary or respiratory drug delivery market consists of sales of metered-dose inhalers (MDIs), dry powder inhalers (DPIs), nebulizers, aerosol formulations, and smart inhalers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pulmonary Or Respiratory Drug Delivery Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses pulmonary or respiratory drug delivery market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pulmonary or respiratory drug delivery ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pulmonary or respiratory drug delivery market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product: Formulation Type; Device Type
• 2) By Canister Type: Plain Canister; Coated Canister
• 3) By Application: Chronic Obstructive Pulmonary Disease; Asthma; Cystic Fibrosis; Other Applications
• 4) By End-User: Hospitals; Clinics; Home Care Settings
• Subsegments:
• 1) By Formulation Type: Dry Powder Inhalers (DPIs); Metered Dose Inhalers (MDIs); Nebulizers; Liquid Aerosols; Nasal Sprays
• 2) By Device Type: Inhalers (Manual and Digital); Nebulizers (Compressor, Ultrasonic, Mesh); Breath-Activated Devices; Spacer Devices; Nasal Drug Delivery Devices
• Companies Mentioned: Merck & Co. Inc.; Novartis AG; Thermo Fisher Scientific Inc.; AstraZeneca plc; Abbott Laboratories; 3M Company; Koninklijke Philips N.V.; GlaxoSmithKline; Omron Corporation; Teva Pharmaceutical Industries Ltd.; Aptar Pharma; Sumitomo Pharma America Inc.; Chiesi Farmaceutici S.p.A.; Cipla Inc.; Boehringer Ingelheim GmbH; Kindeva Drug Delivery Limited; Nemera Group; Hovione; H And T Presspart Group; Vectura Group plc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Pulmonary Or Respiratory Drug Delivery Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Pulmonary Or Respiratory Drug Delivery Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Pulmonary Or Respiratory Drug Delivery Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Pulmonary Or Respiratory Drug Delivery Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.2 Industry 4.0 & Intelligent Manufacturing
  • 4.1.3 Biotechnology, Genomics & Precision Medicine
  • 4.1.4 Artificial Intelligence & Autonomous Intelligence
  • 4.1.5 Sustainability, Climate Tech & Circular Economy
• 4.2. Major Trends
  • 4.2.1 Rising Adoption Of Inhalation-Based Drug Delivery
  • 4.2.2 Increasing Demand For Home-Based Respiratory Therapies
  • 4.2.3 Growing Use Of Dry Powder And Metered Dose Inhalers
  • 4.2.4 Expansion Of Chronic Respiratory Disease Management
  • 4.2.5 Increased Focus On Patient-Friendly Delivery Devices

5. Pulmonary Or Respiratory Drug Delivery Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Clinics
• 5.3 Home Care Settings
• 5.4 Specialty Respiratory Centers
• 5.5 Ambulatory Care Centers

6. Pulmonary Or Respiratory Drug Delivery Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Pulmonary Or Respiratory Drug Delivery Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Pulmonary Or Respiratory Drug Delivery PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Pulmonary Or Respiratory Drug Delivery Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Pulmonary Or Respiratory Drug Delivery Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Pulmonary Or Respiratory Drug Delivery Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Pulmonary Or Respiratory Drug Delivery Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Pulmonary Or Respiratory Drug Delivery Market Segmentation

• 9.1. Global Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Formulation Type, Device Type
• 9.2. Global Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Plain Canister, Coated Canister
• 9.3. Global Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Chronic Obstructive Pulmonary Disease, Asthma, Cystic Fibrosis, Other Applications
• 9.4. Global Pulmonary Or Respiratory Drug Delivery Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals, Clinics, Home Care Settings
• 9.5. Global Pulmonary Or Respiratory Drug Delivery Market, Sub-Segmentation Of Formulation Type, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Dry Powder Inhalers (DPIs), Metered Dose Inhalers (MDIs), Nebulizers, Liquid Aerosols, Nasal Sprays
• 9.6. Global Pulmonary Or Respiratory Drug Delivery Market, Sub-Segmentation Of Device Type, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Inhalers (Manual and Digital), Nebulizers (Compressor, Ultrasonic, Mesh), Breath-Activated Devices, Spacer Devices, Nasal Drug Delivery Devices

10. Pulmonary Or Respiratory Drug Delivery Market Regional And Country Analysis

• 10.1. Global Pulmonary Or Respiratory Drug Delivery Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Pulmonary Or Respiratory Drug Delivery Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Pulmonary Or Respiratory Drug Delivery Market

• 11.1. Asia-Pacific Pulmonary Or Respiratory Drug Delivery Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Segmentation By Canister Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Pulmonary Or Respiratory Drug Delivery Market

• 12.1. China Pulmonary Or Respiratory Drug Delivery Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Segmentation By Canister Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Pulmonary Or Respiratory Drug Delivery Market

• 13.1. India Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Segmentation By Canister Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Pulmonary Or Respiratory Drug Delivery Market

• 14.1. Japan Pulmonary Or Respiratory Drug Delivery Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Segmentation By Canister Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Pulmonary Or Respiratory Drug Delivery Market

• 15.1. Australia Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Segmentation By Canister Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Pulmonary Or Respiratory Drug Delivery Market

• 16.1. Indonesia Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Segmentation By Canister Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Pulmonary Or Respiratory Drug Delivery Market

• 17.1. South Korea Pulmonary Or Respiratory Drug Delivery Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Segmentation By Canister Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Pulmonary Or Respiratory Drug Delivery Market

• 18.1. Taiwan Pulmonary Or Respiratory Drug Delivery Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Segmentation By Canister Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Pulmonary Or Respiratory Drug Delivery Market

• 19.1. South East Asia Pulmonary Or Respiratory Drug Delivery Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Segmentation By Canister Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Pulmonary Or Respiratory Drug Delivery Market

• 20.1. Western Europe Pulmonary Or Respiratory Drug Delivery Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Segmentation By Canister Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Pulmonary Or Respiratory Drug Delivery Market

• 21.1. UK Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Segmentation By Canister Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Pulmonary Or Respiratory Drug Delivery Market

• 22.1. Germany Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Segmentation By Canister Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Pulmonary Or Respiratory Drug Delivery Market

• 23.1. France Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Segmentation By Canister Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Pulmonary Or Respiratory Drug Delivery Market

• 24.1. Italy Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Segmentation By Canister Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Pulmonary Or Respiratory Drug Delivery Market

• 25.1. Spain Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Segmentation By Canister Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Pulmonary Or Respiratory Drug Delivery Market

• 26.1. Eastern Europe Pulmonary Or Respiratory Drug Delivery Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Segmentation By Canister Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Pulmonary Or Respiratory Drug Delivery Market

• 27.1. Russia Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Segmentation By Canister Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Pulmonary Or Respiratory Drug Delivery Market

• 28.1. North America Pulmonary Or Respiratory Drug Delivery Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Segmentation By Canister Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Pulmonary Or Respiratory Drug Delivery Market

• 29.1. USA Pulmonary Or Respiratory Drug Delivery Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Segmentation By Canister Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Pulmonary Or Respiratory Drug Delivery Market

• 30.1. Canada Pulmonary Or Respiratory Drug Delivery Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Segmentation By Canister Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Pulmonary Or Respiratory Drug Delivery Market

• 31.1. South America Pulmonary Or Respiratory Drug Delivery Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Segmentation By Canister Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Pulmonary Or Respiratory Drug Delivery Market

• 32.1. Brazil Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Segmentation By Canister Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Pulmonary Or Respiratory Drug Delivery Market

• 33.1. Middle East Pulmonary Or Respiratory Drug Delivery Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Segmentation By Canister Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Pulmonary Or Respiratory Drug Delivery Market

• 34.1. Africa Pulmonary Or Respiratory Drug Delivery Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Segmentation By Canister Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Pulmonary Or Respiratory Drug Delivery Market Regulatory and Investment Landscape

36. Pulmonary Or Respiratory Drug Delivery Market Competitive Landscape And Company Profiles

• 36.1. Pulmonary Or Respiratory Drug Delivery Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Pulmonary Or Respiratory Drug Delivery Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Pulmonary Or Respiratory Drug Delivery Market Company Profiles
  • 36.3.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

37. Pulmonary Or Respiratory Drug Delivery Market Other Major And Innovative Companies

• 3M Company, Koninklijke Philips N.V., GlaxoSmithKline, Omron Corporation, Teva Pharmaceutical Industries Ltd., Aptar Pharma, Sumitomo Pharma America Inc., Chiesi Farmaceutici S.p.A., Cipla Inc., Boehringer Ingelheim GmbH, Kindeva Drug Delivery Limited, Nemera Group, Hovione, H And T Presspart Group, Vectura Group plc

38. Global Pulmonary Or Respiratory Drug Delivery Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Pulmonary Or Respiratory Drug Delivery Market

40. Pulmonary Or Respiratory Drug Delivery Market High Potential Countries, Segments and Strategies

• 40.1 Pulmonary Or Respiratory Drug Delivery Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Pulmonary Or Respiratory Drug Delivery Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Pulmonary Or Respiratory Drug Delivery Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer